Optimal approaches for the use of DTP-HepB-Hib vaccines in Uniject™ in resource-poor settings
Main Authors: | E. Guillermet, H.M. Dicko, M. Le Thi Phuong, F. Hane, P. Jaillard, B.D. Gessner, A. Colombini |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2014-04-01
|
Series: | International Journal of Infectious Diseases |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1201971214013885 |
Similar Items
-
DTaP5-IPV-Hib-HepB, a hexavalent vaccine for infants and toddlers
by: Andrew W. Lee, et al.
Published: (2017-02-01) -
Safety and immunogenicity of a fully-liquid DTaP-IPV-Hib-HepB vaccine (Vaxelis™) in premature infants
by: Marissa B. Wilck, et al.
Published: (2021-01-01) -
Safety and Immunogenicity of Fully Liquid Hexavalent DTaP-IPV-HepB-Hib Vaccine in Healthy Infants in Russian Federation
by: L. S. Namazova-Baranova, et al.
Published: (2019-06-01) -
A phase III randomized-controlled study of safety and immunogenicity of DTwP-HepB-IPV-Hib vaccine (HEXASIIL®) in infants
by: Hitt Sharma, et al.
Published: (2024-02-01) -
Safety and immunogenicity of a new formulation of a pentavalent DTwP-HepB-Hib vaccine in healthy Indian infants-A randomized study.
by: Naveena Aloysia D'Cor, et al.
Published: (2023-01-01)